Bruce Lucas - 30 Apr 2026 Form 4 Insider Report for Slide Insurance Holdings, Inc. (SLDE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 May 2026, 20:32:25 UTC
Prior SEC filing
29 Apr 2026
Next SEC filing
11 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andy Omiridis, Attorney-in-Fact for Bruce Lucas

Key filing fact

Bruce Lucas filed Form 4 for Slide Insurance Holdings, Inc. (SLDE) on 04 May 2026.

Key facts

  • This page summarizes Bruce Lucas's Form 4 filing for Slide Insurance Holdings, Inc. (SLDE).
  • 7 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 04 May 2026, 20:32.

Change

  • Previous filing in this sequence was filed on 29 Apr 2026.
  • Current net transaction value: -$2,872,464.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001552968 Primary reporting owner

Lucas Bruce

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
C/O SLIDE INSURANCE HOLDINGS, INC., 4221 W. BOY SCOUT BLVD., SUITE 200, TAMPA
Signature
/s/ Andy Omiridis, Attorney-in-Fact for Bruce Lucas
Signature date
04 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLDE transaction

Common Stock

Options Exercise

Transaction value
Shares
+22,918
Change %
+2%
Price
$0.000000*
Shares after
1,160,464
Date
30 Apr 2026
Ownership
Direct
SLDE transaction

Common Stock

Tax liability

Transaction value
Shares
-9,019
Change %
-0.78%
Price
$18.65*
Shares after
1,151,445
Date
30 Apr 2026
Ownership
Direct
SLDE transaction

Common Stock

Sale

Transaction value
$1,603,634
Shares
-85,436
Change %
-0.23%
Price
$18.77
Shares after
36,485,568
Date
01 May 2026
Ownership
By IIM Holdings II, LLC
Footnotes
F1, F2, F3
SLDE transaction

Common Stock

Sale

Transaction value
$1,268,830
Shares
-67,205
Change %
-0.18%
Price
$18.88
Shares after
36,418,363
Date
04 May 2026
Ownership
By IIM Holdings II, LLC
Footnotes
F1, F3, F4
SLDE transaction

Common Stock

Options Exercise

Transaction value
Shares
+22,918
Change %
+12%
Price
$0.000000*
Shares after
222,000
Date
30 Apr 2026
Ownership
By Spouse
Footnotes
F5, F6
SLDE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,575,837
Date
30 Apr 2026
Ownership
By Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014
SLDE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,308,133
Date
30 Apr 2026
Ownership
By Spouse
Footnotes
F7, F8
SLDE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,925,000
Date
30 Apr 2026
Ownership
By Emma Cloonen Irrevocable Trust
Footnotes
F9
SLDE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,925,000
Date
30 Apr 2026
Ownership
By Ava Cloonen Irrevocable Trust
Footnotes
F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDE transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-22,918
Change %
-11%
Price
$0.000000*
Shares after
185,307
Date
30 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,918
Exercise price
Footnotes
F11, F12
SLDE transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-22,918
Change %
-11%
Price
$0.000000*
Shares after
185,307
Date
30 Apr 2026
Ownership
By Spouse
Underlying class
Common Stock
Underlying amount
22,918
Exercise price
Footnotes
F6, F11, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 12 footnotes

Footnote F1

Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.

Footnote F2

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.75 to $18.90 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F3

The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F4

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.80 to $19.06 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F5

The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,918 restricted stock units on April 30, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.

Footnote F6

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F7

The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 15,097 shares of common stock between May 1-4, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.75 to $19.06 per share.

Footnote F8

Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F9

Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F10

Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F11

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock

Footnote F12

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .